10x Genomics (TXG)或报负收益:下周财报发布前了解趋势 - 雅虎财经
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
生物技术与制药领域的最新动态
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance
PharosAI partners with 10x Genomics on spatial cancer data backed by £18.9 million - European Biotechnology Magazine
UK consortium to use 10x Genomics platform for AI-driven cancer research - Investing.com Canada
PharosAI and 10x Genomics partner to transform cancer research with AI and spatial biology - marketscreener.com
Pharosai and 10X Genomics Partner to Transform Cancer Research with Ai and Spatial Biology - marketscreener.com
UK consortium to use 10x Genomics platform for AI-driven cancer research - Investing.com
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology - PR Newswire
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology - Yahoo Finance
10x Genomics (NASDAQ:TXG) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Rate Hike: Can 10x Genomics Inc grow without dilution - July 2025 Summary & High Return Trade Guides - baoquankhu1.vn
UPC Clarifies PI Costs Breakdown In mRNA Fight - Law360
Foundations Investment Advisors LLC Takes Position in 10x Genomics $TXG - MarketBeat
10x Genomics $TXG Holdings Decreased by Federated Hermes Inc. - MarketBeat
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Shares in 10x Genomics $TXG - MarketBeat
AlphaQuest LLC Increases Holdings in 10x Genomics $TXG - MarketBeat
Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? - Yahoo Finance
Ex-CEO Behind Bars, 10x’s Clinical Ambitions, Pharma’s AI Gambit - Genetic Engineering and Biotechnology News
Improving atlas-scale single-cell annotation models with hierarchical cross-entropy loss - Nature
4 Best Genetic Sequencing Stocks To Buy in 2026 - The Motley Fool